|
Nov 10
|
AMGEN PRESENTS NEW CARDIOVASCULAR RESEARCH AT AHA 2023
|
|
Nov 10
|
12 Dogs of the Dow Dividend Stocks to Buy
|
|
Nov 9
|
US Senator Elizabeth Warren expresses 'disappointment' in FTC's Amgen decision
|
|
Nov 9
|
Top 20 Drug Companies in the US by Revenue
|
|
Nov 7
|
AMGEN PRESENTS NEW RESEARCH IN EARLY PSORIATIC ARTHRITIS AT ACR 2023
|
|
Nov 7
|
AMGEN PRESENTS NEW DATA FROM PHASE 2 TRIAL OF DAZODALIBEP IN SJÖGREN'S SYNDROME AT ACR 2023
|
|
Nov 7
|
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
|
|
Nov 6
|
Epidemiology and Genetics of Clonal Hematopoiesis, a Premalignant Hematopoietic Stem Cell Condition
|
|
Nov 6
|
Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It
|
|
Nov 2
|
AMGEN PRESENTS NEW DATA THAT SHOW BLOOD PRESSURE DECREASES FOR ADULTS TREATED WITH KRYSTEXXA® (PEGLOTICASE)
|
|
Nov 2
|
Amazon headed for rosy period, says HSBC; Roku flying: 6 big analyst picks
|
|
Nov 2
|
The Amgen Inc (AMGN) Company: A Short SWOT Analysis
|
|
Nov 1
|
Amgen Inc. (NASDAQ:AMGN) Q3 2023 Earnings Call Transcript
|
|
Nov 1
|
AMGEN TO PRESENT DATA AT ACR 2023 ACROSS EXPANDED RHEUMATOLOGY PIPELINE AND PORTFOLIO
|
|
Nov 1
|
Company News for Nov 01, 2023
|
|
Nov 1
|
Q3 2023 Amgen Inc Earnings Call
|
|
Oct 31
|
S&P 500 Gains and Losses Today: Arista Networks Results and Guidance Beat Estimates
|
|
Oct 31
|
Amgen Tumbles After Scrapping A $900 Million Prostate Cancer Drug
|
|
Oct 31
|
Markets Edge Higher at Midday Ahead of Wednesday's Fed Decision
|
|
Oct 31
|
Amgen's obesity drug plans, outlook for 2024
|